Article
Mechanisms of drug resistance in chemotherapy for urogenital carcinoma
1 Sept 1999
Abstract excerpt
Cancer chemotherapy is the principal approach for urogenital cancers. However, the acquisition of resistance to anticancer agents is a critical factor that limits the successful treatment of malignancies. The multidrug resistant (MDR) phenotype has been widely recognized in cancer chemotherapy in urogenital tumors and the mechanisms underlying MDR have also been extensively studied. One of the principle...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
